NCT01305317

Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients

Study of Statins' Effect on Serum IgG, IgA Ang IgM Level in Chronic Hemodialysis Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 74 (actual)
• Sponsor: Hormozgan University of Medical Sciences · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This is double blind randomized controlled trial on the statins effects on serum IgG, IgA and IgM level in chronic hemodialysis patients in Bandarabbas

Detailed description

This study is a randomized controlled trial of statins effect on serum IgG, IgA and IgM level on chronic hemodialysis patients in Bandarabbas. The study is carried out in Hormozgan, Iran. Seventy four patient were randomized either to receive atorvastatin in addition of usual treatment or not. The primary outcomes were serum IgG,IgA and IgM level. The secondary outcome was drug side effects.

Conditions

• Chronic Kidney Disease

Interventions

Type	Name	Description
DRUG	Lipitor	Atorvastatin 20mg daily for 6 months

Timeline

• Start date: 2007-01-01
• Primary completion: 2008-01-01
• Completion: 2010-01-01
• First posted: 2011-02-28
• Last updated: 2011-03-01

Locations

1 site across 1 country: Iran